Indoleamine 2,3 Dioxygenase in Colitis Associated Cancer

结肠炎相关癌症中的吲哚胺 2,3 双加氧酶

基本信息

  • 批准号:
    8079485
  • 负责人:
  • 金额:
    $ 14.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-07-01 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This proposal describes a 5-year training program for the development of an academic research career in gastroenterology. The PI has previous experience in laboratory investigation and is fellowship trained in gastroenterology with a focus in the inflammatory bowel diseases. He is currently expanding his scientific skills in investigation of intestinal inflammation, particularly as it relates to inflammation associated carcinogenesis. Dr William Stenson, an internationally recognized expert in laboratory investigations in intestinal inflammation has an established record of training independent scientists and will provide principle mentorship. To further promote the investigator's scientific development an advisory committee comprising of highly regarded physician scientist with expertise in intestinal inflammation as well as cancer and epithelial cell biology has been established. The research environment at the PI's institution provides a rich network of intellectual and investigational resources to support career development. The proposed research focuses on an enzyme with recognized immunomodulatory properties, Indoleamine 2,3 Dioxygenase (IDO), and its role in chronic intestinal inflammation and inflammation-associated colon-rectal cancer (CRC). The inflammatory bowel diseases and their complications lead to significant morbidity in affected individuals and their families. Colitis associated cancer is one of the most feared complications. Several lines of evidence suggest a role for IDO in these processes; however the area remains largely unexplored. IDO is seen as acting through the inhibition of lymphocyte activation. Our evidence shows that IDO is highly expressed in gut epithelial cells in response to inflammation and toll-like receptor activation. This expression of IDO in epithelial cells serves a protective function in dextran sodium sulfate colitis, a model of epithelial dysfunction which is T-cell independent. The goal of these studies is provide critical insight into the T-cell dependent and epithelial cell dependent functions of IDO in chronic colitis and colitis associated colon cancer, clarifying the potential role of therapeutic agents directed at affecting IDO activity in both colitis and malignancy of the colon. Scientific tools including knockout and transgenic mouse lines will assist in addressing the specific aims including 1) Evaluating the role of IDO in both T-cell dependent and independent models of chronic colitis 2) Determining the role of IDO in colon epithelial and cancer cell proliferation, and 3) Defining T-cell dependent & independent functions of IDO in a model of colitis associated cancer. The larger goal of the applicant and this mentored research grant is to develop the knowledge and skill sets required to become an independent investigator and ask relevant basic questions in mucosal immunology that aid in our understanding of human inflammatory diseases of the gastrointestinal tract. PUBLIC HEALTH RELEVANCE: The goal of these studies is provide critical insight into the lymphocyte dependent and epithelial cell dependent functions of IDO in chronic colitis as and colitis associated colon cancer as occurs in human Crohn's and Ulcerative Colitis. The relevance of this work is to clarifying the potential role of therapeutic agents directed at affecting IDO activity in both colitis and malignancy of the colon.
描述(由申请人提供): 该提案描述了一个为期5年的培训计划,以发展胃肠病学的学术研究事业。PI具有实验室研究的既往经验,并接受过胃肠病学研究员培训,重点关注炎症性肠病。他目前正在扩大他在肠道炎症研究方面的科学技能,特别是因为它与炎症相关的致癌作用有关。William Stenson博士是国际公认的肠道炎症实验室研究专家,在培训独立科学家方面有着良好的记录,并将提供原则指导。为了进一步促进研究者的科学发展,成立了一个咨询委员会,由在肠道炎症以及癌症和上皮细胞生物学方面具有专业知识的德高望重的医生科学家组成。PI机构的研究环境提供了丰富的智力和调查资源网络,以支持职业发展。拟议的研究重点是一种具有公认的免疫调节特性的酶,吲哚胺2,3双加氧酶(IDO),及其在慢性肠道炎症和炎症相关的结肠直肠癌(CRC)中的作用。炎症性肠病及其并发症导致受影响个体及其家庭的显著发病率。结肠炎相关癌症是最可怕的并发症之一。有几方面的证据表明,国际采矿组织在这些进程中发挥了作用;然而,这一领域在很大程度上仍未得到探索。IDO被视为通过抑制淋巴细胞活化而起作用。我们的证据表明,IDO在肠道上皮细胞中高度表达,以响应炎症和toll样受体激活。IDO在上皮细胞中的这种表达在葡聚糖硫酸钠结肠炎中起保护作用,葡聚糖硫酸钠结肠炎是一种不依赖于T细胞的上皮功能障碍模型。这些研究的目标是提供对IDO在慢性结肠炎和结肠炎相关结肠癌中的T细胞依赖性和上皮细胞依赖性功能的关键性见解,阐明针对影响IDO活性的治疗剂在结肠炎和结肠恶性肿瘤中的潜在作用。包括敲除和转基因小鼠系的科学工具将有助于解决具体目标,包括1)评估IDO在慢性结肠炎的T细胞依赖性和非依赖性模型中的作用,2)确定IDO在结肠上皮和癌细胞增殖中的作用,和3)定义IDO在结肠炎相关癌症模型中的T细胞依赖性和非依赖性功能。申请人的更大目标和这个指导研究补助金是发展所需的知识和技能,成为一个独立的研究者,并询问粘膜免疫学的相关基本问题,帮助我们了解人类胃肠道炎性疾病。 公共卫生关系: 这些研究的目的是提供对IDO在慢性结肠炎和结肠炎相关结肠癌中的淋巴细胞依赖性和上皮细胞依赖性功能的关键见解,如在人克罗恩病和溃疡性结肠炎中发生的那样。这项工作的相关性是澄清针对影响IDO活性的治疗剂在结肠炎和结肠恶性肿瘤中的潜在作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MATTHEW AARON CIORBA其他文献

MATTHEW AARON CIORBA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MATTHEW AARON CIORBA', 18)}}的其他基金

Targeting Tryptophan Metabolism in Rectal Cancer
靶向直肠癌中的色氨酸代谢
  • 批准号:
    10754178
  • 财政年份:
    2023
  • 资助金额:
    $ 14.29万
  • 项目类别:
Mechanisms of Gastrointestinal COVID-19
胃肠道 COVID-19 的机制
  • 批准号:
    10538795
  • 财政年份:
    2022
  • 资助金额:
    $ 14.29万
  • 项目类别:
Mechanisms of Gastrointestinal COVID-19
胃肠道 COVID-19 的机制
  • 批准号:
    10467855
  • 财政年份:
    2022
  • 资助金额:
    $ 14.29万
  • 项目类别:
Mechanisms of Gastrointestinal COVID-19
胃肠道 COVID-19 的机制
  • 批准号:
    10665643
  • 财政年份:
    2022
  • 资助金额:
    $ 14.29万
  • 项目类别:
TARGETING TRYPTOPHAN METABOLISM IN COLITIS ASSOCIATED CANCER
针对结肠炎相关癌症中的色氨酸代谢
  • 批准号:
    9270026
  • 财政年份:
    2016
  • 资助金额:
    $ 14.29万
  • 项目类别:
TARGETING TRYPTOPHAN METABOLISM IN COLITIS ASSOCIATED CANCER
针对结肠炎相关癌症中的色氨酸代谢
  • 批准号:
    9083887
  • 财政年份:
    2016
  • 资助金额:
    $ 14.29万
  • 项目类别:
IDO1 IN THE HUMAN GUT EPITHELIUM
人类肠道上皮中的 IDO1
  • 批准号:
    8624339
  • 财政年份:
    2014
  • 资助金额:
    $ 14.29万
  • 项目类别:
IDO1 IN THE HUMAN GUT EPITHELIUM
人类肠道上皮中的 IDO1
  • 批准号:
    8791898
  • 财政年份:
    2014
  • 资助金额:
    $ 14.29万
  • 项目类别:
Indoleamine 2,3 Dioxygenase in Colitis Associated Cancer
结肠炎相关癌症中的吲哚胺 2,3 双加氧酶
  • 批准号:
    7962872
  • 财政年份:
    2010
  • 资助金额:
    $ 14.29万
  • 项目类别:
Indoleamine 2,3 Dioxygenase in Colitis Associated Cancer
结肠炎相关癌症中的吲哚胺 2,3 双加氧酶
  • 批准号:
    8500253
  • 财政年份:
    2010
  • 资助金额:
    $ 14.29万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 14.29万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 14.29万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.29万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.29万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 14.29万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.29万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 14.29万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 14.29万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 14.29万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.29万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了